The 93rd European Atherosclerosis Society (EAS) Congress is dedicated to he latest updates on the complex and multifactorial pathogenesis of atherosclerosis including including:
- Energy metabolism and diabetes
- Cholesterol homeostasis and beta cell function
- Diabetic Dyslipidemia
- Lipotoxic heart disease
- NAFLD and NASH
- Microbiota, immunity and regulation
- Immunity in Atherosclerosis
- Role of Microbiota in Atherosclerosis
- Regulation of vascular cells by microRNAs
- Risk factors and interventions
- Genetic risk factors and Mendelian Randomization
- Classical and Novel Risk Factors
- Beyond statins?
- Residual cardiovascular risk: anything needed or effective
- PCSK9 Inhibition
The 93rd European Atherosclerosis Society (EAS) Congress might be held in 2025.
